These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3676016)

  • 1. Increased vancomycin elimination with continuous hemofiltration.
    Lau AH; Kronfol NO; John E
    ASAIO Trans; 1987; 33(3):772-4. PubMed ID: 3676016
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
    Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of vancomycin during hemofiltration.
    Rawer P; Seim KE
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):529-31. PubMed ID: 2504595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of vancomycin in patients on continuous arteriovenous hemodialysis.
    Reetze-Bonorden P; Böhler J; Kohler C; Schollmeyer P; Keller E
    Contrib Nephrol; 1991; 93():135-9. PubMed ID: 1802564
    [No Abstract]   [Full Text] [Related]  

  • 5. Vancomycin clearance in high-volume venovenous hemofiltration.
    Paciullo CA; Harned KC; Davis GA; Connor MJ; Winstead PS
    Ann Pharmacother; 2013 Mar; 47(3):e14. PubMed ID: 23404801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdosing continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury.
    Ricci Z; Romagnoli S
    J Crit Care; 2011 Apr; 26(2):221; author reply 222. PubMed ID: 21376525
    [No Abstract]   [Full Text] [Related]  

  • 7. Vancomycin disposition during continuous arteriovenous hemofiltration.
    Dupuis RE; Matzke GR; Maddux FW; O'Neil MG
    Clin Pharm; 1989 May; 8(5):371-4. PubMed ID: 2743733
    [No Abstract]   [Full Text] [Related]  

  • 8. Delivered dose of continuous venovenous hemofiltration predicts outcome in septic patients with acute kidney injury: a retrospective study.
    Nurmohamed SA; Koning MV; Vervloet MG; Groeneveld AB
    J Crit Care; 2011 Apr; 26(2):213-20. PubMed ID: 21036524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid removal of vancomycin by continuous veno-venous hemofiltration.
    Shah M; Quigley R
    Pediatr Nephrol; 2000 Sep; 14(10-11):912-5. PubMed ID: 10975298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clearance of vancomycin during continuous arteriovenous hemodiafiltration.
    Bellomo R; Ernest D; Parkin G; Boyce N
    Crit Care Med; 1990 Feb; 18(2):181-3. PubMed ID: 2298011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of vancomycin by continuous arteriovenous hemofiltration.
    Lau AH; John E
    Child Nephrol Urol; 1988-1989; 9(4):232-5. PubMed ID: 3255486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An effect of continuous and intermittent renal replacement therapy on antibiotic treatment in critically ill patients with sepsis - a practice-based perspective of vancomycin and gentamycin therapies].
    Petejová N; Martínek A; Zahálková J; Duricová J; Plášek J; Valkovský I; Grundmann M; Kacířová I
    Vnitr Lek; 2012 Jun; 58(6):448-54. PubMed ID: 22913237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Slow continuous hemofiltration and slow continuous ultrafiltration.
    Paganini EP
    ASAIO Trans; 1988; 34(1):63-6. PubMed ID: 3377916
    [No Abstract]   [Full Text] [Related]  

  • 14. Disposition of vancomycin during hemofiltration.
    Matzke GR; O'Connell MB; Collins AJ; Keshaviah PR
    Clin Pharmacol Ther; 1986 Oct; 40(4):425-30. PubMed ID: 3757406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interpretation of the experts' consensus on continuous blood purification treatment of severe sepsis in children].
    Xu X; Feng ZC
    Zhonghua Er Ke Za Zhi; 2012 Sep; 50(9):684-8. PubMed ID: 23158819
    [No Abstract]   [Full Text] [Related]  

  • 16. [Extracorporeal treatment of acute kidney injury during sepsis].
    Nalesso F; Brendolan A; Zanella M; Ronco C
    G Ital Nefrol; 2012; 29 Suppl 56():S35-40. PubMed ID: 23059938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial.
    Zhang P; Yang Y; Lv R; Zhang Y; Xie W; Chen J
    Nephrol Dial Transplant; 2012 Mar; 27(3):967-73. PubMed ID: 21891773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration.
    De Bock V; Verbeelen D; Maes V; Sennesael J
    Nephrol Dial Transplant; 1989; 4(7):635-9. PubMed ID: 2510061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental and clinical studies of continuous arteriovenous hemofiltration].
    Ota K
    Nihon Rinsho; 1985 Dec; 43(12):2678-83. PubMed ID: 3835320
    [No Abstract]   [Full Text] [Related]  

  • 20. Systemic absorption after local intracolonic vancomycin in pseudomembranous colitis.
    Pasic M; Carrel T; Opravil M; Mihaljevic T; von Segesser L; Turina M
    Lancet; 1993 Aug; 342(8868):443. PubMed ID: 8101948
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.